Of note, genetic inhibition of RIPK3 resulted in a very effective inhibition of liver fibrosis in a murine model of NASH [methionine/choline-deficient (MCD) diet], whereas apoptosis inhibition even increased disease progression (26, 28). This evidence concerns the gene RIPK3 and metabolic dysfunction-associated steatohepatitis.